Zakara Biotechnology Fund LP — Form D/A
Zakara Biotechnology Fund LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2026-04-22. $15K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-04-22
- Form: D/A
- Accession: 0000919574-26-002327
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Amount sold: $15K
- Investors: 1
- Security types: equity, fund interests
- SEC file number: 021-543714
Issuer
- Name: Zakara Biotechnology Fund LP
- CIK: 0002058789
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 300 PARK AVENUE 2ND FLOOR, SUITE 201, NEW YORK, NY, 10022
- Phone: 646 419 8761
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Janet Okogbaa | Related Person | New York, NY |
| - Zakara Capital LLC | Executive Officer | New York, NY |
| - Zakara Capital LLC | Promoter | New York, NY |
| Janet Okogbaa | Executive Officer | New York, NY |
| Janet Okogbaa | Promoter | New York, NY |
| - Zakara Biotechnology Fund GP LLC | Executive Officer | New York, NY |
| - Zakara Biotechnology Fund GP LLC | Promoter | New York, NY |
Other filings by this issuer (1)
More